Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Tumor exome analysis reveals neoantigen-specific T-cell reactivity in an ipilimumab-responsive melanoma.

Literature DB >> 24043743

Tumor exome analysis reveals neoantigen-specific T-cell reactivity in an ipilimumab-responsive melanoma.

Nienke van Rooij¹, Marit M van Buuren, Daisy Philips, Arno Velds, Mireille Toebes, Bianca Heemskerk, Laura J A van Dijk, Sam Behjati, Henk Hilkmann, Dris El Atmioui, Marja Nieuwland, Michael R Stratton, Ron M Kerkhoven, Can Kesmir, John B Haanen, Pia Kvistborg, Ton N Schumacher.

Abstract

Entities: Chemical Disease Gene Species

Mesh：

Substances：

Year: 2013 PMID： 24043743 PMCID： PMC3836220 DOI： 10.1200/JCO.2012.47.7521

Source DB: PubMed Journal: J Clin Oncol ISSN： 0732-183X Impact factor: 44.544

× No keyword cloud information.

22 in total

1. Generation of peptide-MHC class I complexes through UV-mediated ligand exchange.

Authors: Boris Rodenko; Mireille Toebes; Sine Reker Hadrup; Wim J E van Esch; Annemieke M Molenaar; Ton N M Schumacher; Huib Ovaa
Journal: Nat Protoc Date: 2006 Impact factor: 13.491

2. Design and use of conditional MHC class I ligands.

Authors: Mireille Toebes; Miriam Coccoris; Adriaan Bins; Boris Rodenko; Raquel Gomez; Nella J Nieuwkoop; Willeke van de Kasteele; Guus F Rimmelzwaan; John B A G Haanen; Huib Ovaa; Ton N M Schumacher
Journal: Nat Med Date: 2006-02-05 Impact factor: 53.440

Review 3. ATR: an essential regulator of genome integrity.

Authors: Karlene A Cimprich; David Cortez
Journal: Nat Rev Mol Cell Biol Date: 2008-07-02 Impact factor: 94.444

4. Improved survival with ipilimumab in patients with metastatic melanoma.

Authors: F Stephen Hodi; Steven J O'Day; David F McDermott; Robert W Weber; Jeffrey A Sosman; John B Haanen; Rene Gonzalez; Caroline Robert; Dirk Schadendorf; Jessica C Hassel; Wallace Akerley; Alfons J M van den Eertwegh; Jose Lutzky; Paul Lorigan; Julia M Vaubel; Gerald P Linette; David Hogg; Christian H Ottensmeier; Celeste Lebbé; Christian Peschel; Ian Quirt; Joseph I Clark; Jedd D Wolchok; Jeffrey S Weber; Jason Tian; Michael J Yellin; Geoffrey M Nichol; Axel Hoos; Walter J Urba
Journal: N Engl J Med Date: 2010-06-05 Impact factor: 91.245

5. Safety, activity, and immune correlates of anti-PD-1 antibody in cancer.

Authors: Suzanne L Topalian; F Stephen Hodi; Julie R Brahmer; Scott N Gettinger; David C Smith; David F McDermott; John D Powderly; Richard D Carvajal; Jeffrey A Sosman; Michael B Atkins; Philip D Leming; David R Spigel; Scott J Antonia; Leora Horn; Charles G Drake; Drew M Pardoll; Lieping Chen; William H Sharfman; Robert A Anders; Janis M Taube; Tracee L McMiller; Haiying Xu; Alan J Korman; Maria Jure-Kunkel; Shruti Agrawal; Daniel McDonald; Georgia D Kollia; Ashok Gupta; Jon M Wigginton; Mario Sznol
Journal: N Engl J Med Date: 2012-06-02 Impact factor: 91.245

Review 6. The cancer antigenome.

Authors: Bianca Heemskerk; Pia Kvistborg; Ton N M Schumacher
Journal: EMBO J Date: 2012-12-21 Impact factor: 11.598

7. Epitope landscape in breast and colorectal cancer.

Authors: Neil H Segal; D Williams Parsons; Karl S Peggs; Victor Velculescu; Ken W Kinzler; Bert Vogelstein; James P Allison
Journal: Cancer Res Date: 2008-02-01 Impact factor: 12.701

8. Can the exome and the immunome converge on the design of efficient cancer vaccines?

Authors: Guido Kroemer; Laurence Zitvogel
Journal: Oncoimmunology Date: 2012-08-01 Impact factor: 8.110

9. Exome sequencing identifies recurrent somatic RAC1 mutations in melanoma.

Authors: Michael Krauthammer; Yong Kong; Byung Hak Ha; Perry Evans; Antonella Bacchiocchi; James P McCusker; Elaine Cheng; Matthew J Davis; Gerald Goh; Murim Choi; Stephan Ariyan; Deepak Narayan; Ken Dutton-Regester; Ana Capatana; Edna C Holman; Marcus Bosenberg; Mario Sznol; Harriet M Kluger; Douglas E Brash; David F Stern; Miguel A Materin; Roger S Lo; Shrikant Mane; Shuangge Ma; Kenneth K Kidd; Nicholas K Hayward; Richard P Lifton; Joseph Schlessinger; Titus J Boggon; Ruth Halaban
Journal: Nat Genet Date: 2012-07-29 Impact factor: 38.330

10. NetMHC-3.0: accurate web accessible predictions of human, mouse and monkey MHC class I affinities for peptides of length 8-11.

Authors: Claus Lundegaard; Kasper Lamberth; Mikkel Harndahl; Søren Buus; Ole Lund; Morten Nielsen
Journal: Nucleic Acids Res Date: 2008-05-07 Impact factor: 16.971

385 in total

1. Recurrence of melanoma following T cell treatment: continued antigen expression in a tumor that evades T cell recruitment.

Authors: Trudy Straetemans; Cor Berrevoets; Miriam Coccoris; Elike Treffers-Westerlaken; Rebecca Wijers; David K Cole; Valerie Dardalhon; Andrew K Sewell; Naomi Taylor; Jaap Verweij; Reno Debets
Journal: Mol Ther Date: 2014-11-03 Impact factor: 11.454

Review 2. Universes collide: combining immunotherapy with targeted therapy for cancer.

Authors: Jennifer A Wargo; Zachary A Cooper; Keith T Flaherty
Journal: Cancer Discov Date: 2014-11-13 Impact factor: 39.397

3. Patient HLA class I genotype influences cancer response to checkpoint blockade immunotherapy.

Authors: Diego Chowell; Luc G T Morris; Claud M Grigg; Jeffrey K Weber; Robert M Samstein; Vladimir Makarov; Fengshen Kuo; Sviatoslav M Kendall; David Requena; Nadeem Riaz; Benjamin Greenbaum; James Carroll; Edward Garon; David M Hyman; Ahmet Zehir; David Solit; Michael Berger; Ruhong Zhou; Naiyer A Rizvi; Timothy A Chan
Journal: Science Date: 2017-12-07 Impact factor: 47.728

Review 4. Drug development in the era of precision medicine.

Authors: Sarah A Dugger; Adam Platt; David B Goldstein
Journal: Nat Rev Drug Discov Date: 2017-12-08 Impact factor: 84.694

5. Isolation of neoantigen-specific T cells from tumor and peripheral lymphocytes.

Authors: Cyrille J Cohen; Jared J Gartner; Miryam Horovitz-Fried; Katerina Shamalov; Kasia Trebska-McGowan; Valery V Bliskovsky; Maria R Parkhurst; Chen Ankri; Todd D Prickett; Jessica S Crystal; Yong F Li; Mona El-Gamil; Steven A Rosenberg; Paul F Robbins
Journal: J Clin Invest Date: 2015-09-21 Impact factor: 14.808

6. Tumor antigenicity revealed.

Authors: Peter A Savage
Journal: Trends Immunol Date: 2014-01-15 Impact factor: 16.687

7. Cancer immunology. Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer.

Authors: Naiyer A Rizvi; Matthew D Hellmann; Alexandra Snyder; Pia Kvistborg; Vladimir Makarov; Jonathan J Havel; William Lee; Jianda Yuan; Phillip Wong; Teresa S Ho; Martin L Miller; Natasha Rekhtman; Andre L Moreira; Fawzia Ibrahim; Cameron Bruggeman; Billel Gasmi; Roberta Zappasodi; Yuka Maeda; Chris Sander; Edward B Garon; Taha Merghoub; Jedd D Wolchok; Ton N Schumacher; Timothy A Chan
Journal: Science Date: 2015-03-12 Impact factor: 47.728